진매트릭스

109820KOSDAQ

50.0 / 100

Reference Date: 2026-10-23

Financial Score18.5 / 40

News Sentiment12.5 / 25

Momentum9.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 6.9% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

JinMatrix is a biotechnology company established in 2000, specializing in the development of pharmaceuticals and diagnostic kits using proprietary technologies such as C-Tag and Encleap. Its flagship product, NeoPlex, enables the simultaneous detection of multiple pathogens, including sexually transmitted infections, tuberculosis, and HPV, and the company is expanding into global molecular diagnostics markets, particularly in Europe.

Number of Employees

69people

Average Salary

47.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

1.75Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE

-10.00Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

29.33Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20254.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲4.2% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲47.1% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -10.5% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (14%, downtrend)

Current 1,495Won52-week high 2,54552-week low 1,314

1-month return2.0Point

1m -6.91% (slight drop)

Volume trend6.0Point

Volume surge

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral[기재정정]반기보고서 (2026.06)2026-09-30